Celularity (CELU) director receives 30,000 RSUs and holds 520,021 shares

Rhea-AI Filing Summary

Celularity Inc. director Diane L. Parks received an award of 30,000 restricted stock units (RSUs) of Class A common stock on January 12, 2026, reported at a grant price of $0 per share. Each RSU represents the right to receive one share of Class A common stock.

The RSUs vest on the earlier of the one-year anniversary of the grant date and the next annual stockholder meeting, if she continues serving the company through that date. Following this grant, she beneficially owns 520,021 shares of Class A common stock, including the new RSUs granted under the 2021 Equity Incentive Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parks Diane L.

(Last) (First) (Middle)

C/O CELULARITY INC.

170 PARK AVENUE

(Street)

FLORHAM PARK NJ 07932

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celularity Inc [ CELU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/12/2026		A		30,000(1)	A	$0	520,021(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

2. Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.

	/s/ Diane Parks	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Celularity Inc (CELU) report for Diane Parks in this Form 4?

The filing shows that director Diane L. Parks received 30,000 restricted stock units (RSUs) of Celularity Inc. Class A common stock as an equity grant.

What are the vesting terms of Diane Parks' 30,000 RSUs at Celularity Inc (CELU)?

The 30,000 RSUs vest and become exercisable on the earlier of the one-year anniversary of the grant date and the next annual stockholder meeting, if she remains in continuous service with Celularity Inc. through that date.

What is Diane Parks' total beneficial ownership after this RSU grant at Celularity Inc (CELU)?

After the reported transaction, Diane L. Parks beneficially owns 520,021 shares of Celularity Inc. Class A common stock, including the 30,000 RSUs granted under the 2021 Equity Incentive Plan.

At what price were the 30,000 RSUs granted to Diane Parks by Celularity Inc (CELU)?

The 30,000 RSUs were reported with a grant price of $0 per share, consistent with typical reporting for restricted stock units awarded as compensation rather than purchased in the market.

What plan governs the RSU grant to Diane Parks at Celularity Inc (CELU)?

The RSUs were granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing the right to receive one share of the company’s Class A common stock.

Is Diane Parks a director or officer of Celularity Inc (CELU) in this filing?

The filing identifies Diane L. Parks as a director of Celularity Inc. and indicates she is not reported as an officer or 10% owner.